Skip to main content

Table 2 Treatment details

From: Association of oesophageal radiation dose volume metrics, neutropenia and acute radiation oesophagitis in patients receiving chemoradiotherapy for non-small cell lung cancer

Variable Category Count %
RT dose received <60Gy 12 22.2
  60Gy 42 77.8
RT type High dose palliative 10 18.5
  Radical 44 81.5
RT breaks No 54 100
  Yes 0 0
Chemo regimen Carboplatin + paclitaxel + gefitinib 4 7.4
  Carboplatin + paclitaxel weekly 20 37
  Carboplatin weekly 3 5.6
  Carboplatin weeks 1 and 6 17 31.5
  Gemcitabine weekly 8 14.8
  Vinorelbine + Cisplatin weekly 2 3.7
Neoadjuvant chemo No 52 96.3
  Yesa 2 3.7
NGPEG pre CRT No 54 100
  Yes 0 0
NGPEG during CRT No 53 98.1
  Yes 1 1.9
Steroids pretreatment No 49 90.7
  Yes 5 9.3
Steroids during No 27 50
  Yes 27 50
PPI pre No 45 83.3
  Yes 9 16.7
PPI during No 34 63
  Yes 20 37
H2Antag pre CRT No 52 96.3
  Yes 2 3.7
H2Antag during CRT No 46 85.2
  Yes 8 14.8
Local analgesia No 17 31.5
  Yes 37 68.5
Type local analgesia Aluminium hydroxide and oxethazaine (Mucaine) 12 32.4
  Lignocaine viscous and Mucaine 22 59.5
  Lignocaine viscous only 3 8.1
Systemic analgesia No 18 33.3
  Yes 36 66.7
Type sys analgesia non-opioid 8 22.2
  strong opioid 21 58.3
  weak opioid 7 19.4
  1. aOf the 2 patients who received neoadjuvant chemotherapy, 1 received Carboplatin + Paclitaxel weekly and 1 received Carboplatin + Gemcitabine
  2. NGPEG Nasogastric tube or PEG
  3. PPI proton pump inhibitor
  4. H2antag Histamine H2 receptor antagonist